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Background: The Minor Ailment Service (MAS) in Scottish community pharmacy allows eligible people to gain improved access to care 
by providing free treatment for self-limiting conditions.  
Objective: To determine the perceptions and experiences of individuals using MAS and to quantify the potential impact on usage of 
other healthcare services.  
Methods: A cross-sectional survey was conducted of patients accessing MAS across Scotland during June and July 2018. Questionnaire 
items included reasons for choosing treatment through MAS, which other services they may have accessed had MAS not been 
available, experiences of consultation, overall satisfaction, and perceived effectiveness of treatment. Those accessing MAS were given 
a study pack including an information sheet, pre-piloted questionnaire, and pre-paid return envelope. Participants had the option to 
consent to an optional one-week follow up questionnaire that focused on perceived effectiveness of treatment after seven days and 
any further access to healthcare services such as general practice, emergency departments or repeat pharmacy visits.   
Results: There were 1,121 respondents to the initial questionnaire. Most reported ‘convenient Location’ as the main reason for their 
access to community pharmacy (n=748; 67.1%). If MAS had not been available, 59% (n=655) of participants reported that they would 
have accessed general practice for treatment of their minor ailment. Experience of consultations was also rated highly with all ten 
outcome measures scoring ‘Excellent’ overall. Satisfaction was reported positively with most participants reporting full satisfaction 
with the overall experience (n=960; 87.2%). At one-week follow up, 327 participants responded, over 85% (n=281) did not require 
further access to care to treat their minor ailment and 99.7% (n=326) said they would use MAS again.   
Conclusions: Positive perceptions and experiences of those using MAS demonstrate a highly regarded service in terms of satisfaction 
and experience of consultation. The capacity for MAS to impact on the use of higher-cost healthcare services is evidenced through the 
number of participants who reported these services as a point of access to care should community pharmacy not be available. This 
national evaluation demonstrates MAS to be a positively experienced service and outlines the factors determining access for 
treatment of minor ailments. 
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INTRODUCTION 
National Health Service (NHS) Scotland has described the 
necessity for delivering high quality and sustainable health 
services based on new models of community-based 
care.1,2,3 The Minor Ailment Service (MAS) in Scotland 
provides local treatment and advice at no cost to the 
patient, for self-limiting conditions such as coughs, colds, 
gastrointestinal symptoms, or musculoskeletal pain.4 MAS, 
established in 2006, is a core element of the Community 
Pharmacy Contract in Scotland which allows eligible 
patients to receive free treatment for self-limiting 
conditions.5,6 The formulary-based approach to treatment 
provides non-prescription medications and advice from a 
trained pharmacy-based team led by a qualified 
pharmacist. MAS, in Scotland, is open to those under the 
age of 16, under the age of 19 in full-time education, aged 
60 years and over, receiving specific income-related 
support benefits, or with maternity, medical or pension 
exemption certificates. MAS shifts demand for treatment 
away from higher cost healthcare settings, such as general 
practice and accident and emergency, to the local 
community pharmacy contributing to easier and quicker 
access to healthcare, in most cases, without the need for 
an appointment.1,7  
In Scotland, minor ailments comprise an estimated 5% and 
13% of consultations at accident and emergency 
departments and general practice respectively, at an 
annual cost of GBP 1.1 billion.6 The Scottish Health Council 
reviewed public perception of community pharmacy in 
2013 and within this larger project, received some positive 
feedback from those who had accessed MAS.8 
In the wider United Kingdom (UK), it has been shown that a 
reliance on higher cost healthcare services not only equates 
to a higher prescribing cost but also contributes to the 
workload and perceived burden for staff.9,10 This not only 
limits access for patients with more serious conditions that 
could not be treated at a community pharmacy but 
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contributes to the perceived burnout rates among general 
practitioners.11 The current evidence base of clinical 
outcomes of pharmacy based management of minor 
ailments is critiqued to be limited and community 
pharmacists have reported concerns with their confidence 
in providing services beyond prescription provision.7,12 
However, a recent study conducted in the UK has shown 
that patients prefer community pharmacy staff to display 
professionalism and operate in a person-centred manner 
which would include those accessing MAS.13 Systematic 
reviews of UK community pharmacy suggests appropriate 
treatment of minor ailments demonstrated by low rates of 
reconsultation and high rates of symptom resolution.14 
MAS also exists internationally and, while there may be 
different means of service delivery and different structural 
features, the core standards remain consistent. Australia 
has recently shown that their MAS system provides better 
clinical outcomes than usual pharmacy care and has been 
shown to be a financially viable option for their community 
pharmacy services.15,16 In Canada, the equivalent service, 
named Pharmacists Prescribing for Minor Ailments, was 
evaluated in the Saskatchewan province, and was found to 
be cost saving overall with improved access to care for the 
general public.17 MAS has also been considered in other 
countries such as Ireland and New Zealand, indicative of 
the expansion of such a service to more countries in the 
future as they balance financial viability of healthcare with 
the increasing demands of access to care.18,19 
Perception of MAS is restricted in the existing literature to 
the perspectives of staff and stakeholders, although, public 
perceptions of general pharmacy practice, preferences for 
self-care and professional advice and the management of 
minor illnesses have been reported.10,20,21 Furthermore, it 
has the potential to provide the same standard of care as 
higher cost healthcare services to shift demand for the 
treatment of minor ailments towards community 
pharmacy.7 The understanding of patient perceptions and 
experiences are necessary to demonstrate the capabilities 
of community pharmacy. It is also necessary to understand 
the informed reasoning of healthcare service choice and 
patient satisfaction to ensure that the services of 
community pharmacies in Scotland are properly utilised 
and pharmacy service models are implemented to 
maximise service uptake.  
This project aimed to determine the perceptions and 
experiences of those who accessed MAS from community 
pharmacies in Scotland. This national cross-sectional 
evaluation of MAS provides a baseline to assess the future 
development and refinement of community pharmacy 




This study was a cross-sectional survey with a one-week 
outcome follow-up.  
Questionnaire development  
Questionnaire items for both the initial and one-week 
follow-up questionnaires were informed by the literature, 
previous service evaluation projects and Scottish public 
health reports.8,21 Think aloud testing was also conducted 
among members of the research team and international 
PhD students exploring face and content validity to ensure 
that the questionnaires asked questions in the right way 
and were appropriate to answer the overall study research 
questions.22 Questionnaires were pilot tested in four 
pharmacies to ensure both the content of questionnaires 
and logistics of distribution, questionnaire return, and data 
entry were appropriate. These pharmacies were selected 
due to their diversity of setting, i.e. urban and rural, and 
relative deprivation based on site postcode of the Scottish 
Index of Multiple Deprivation.23 Within the pilot, 228 
patients were recruited from four community pharmacies 
to provide feedback and gauge the acceptability and 
accessibility of the questionnaire.  
Initial questionnaire items were designed to elicit 
sociodemographics of participants (sex, occupational 
status, MAS eligibility, previous MAS use, and who they 
were accessing the service for), duration of symptoms of 
their minor ailment, their reasons for accessing community 
pharmacy services, which other services they thought they 
would have accessed had MAS not been available, 
experiences of the consultation (based on the CARE 
Measure), and overall satisfaction.24 The one-week follow-
up questionnaire asked if participants had accessed any 
further service for treatment of their initial minor ailment, 
whether they felt that their minor ailment had been 
treated effectively, if they would use MAS again, and 
whether they would recommend MAS to others. 
Sociodemographics and duration of illness or symptoms 
were collected to gauge whether the sample population of 
this study was representative or transferable to the general 
population accessing community pharmacy in Scotland. 
Reasons for choosing to access community pharmacy 
services were asked as closed yes or no questions, as were 
the responses for which services they thought they would 
have accessed had MAS not been available. The CARE 
measure was used to measure patient perceptions of 
‘consultation and relational empathy’ (CARE). Ten aspects 
of consultation and relational empathy such as ‘really 
listening’ and ‘being interested in you as a whole person’ 
were rated by patients on a five-point Likert scale ranging 
from ‘poor’ to ‘excellent’. Overall satisfaction of the 
experience of using MAS was rated by patients from 1 to 
10, with 1 representing ‘Not at all satisfied’ and 10 ‘Fully 
satisfied’. At follow-up participants were asked whether 
they felt their minor ailment had been effectively treated, if 
they would use the service again, and if they would 
recommend the service to others for treatment of minor 
illnesses. 
Both initial and follow-up questionnaires were provided via 
a link to an online version using SurveyMonkey®, to 
promote response rates by improving access, alternatively 
patients were asked to return their completed printed 
version of the questionnaire by pre-paid post as soon after 
their pharmacy visit as possible. The optional follow-up 
questionnaire allowed further determination of which 
other healthcare services had been accessed or not 
required by ascertaining if any subsequent appointment 
was made to treat the initial minor ailment. Patients were 
asked whether they believed that their MAS treatment was 
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effective, whether they would use MAS again, and whether 
they would recommend the service to others.  
Recruitment  
Community pharmacies were informed of the study by 
Community Pharmacy Scotland newsletters, social media 
updates and a blog on the membership website where they 
outlined the purpose and processes of the study. Every 
community pharmacy in Scotland (n=1,249) was eligible for 
inclusion and only two pharmacies actively opted out: 
pharmacies could opt put without giving a reason. An 
envelope containing 10 study packs - each with an 
information sheet, questionnaire, and pre-paid return 
envelope was sent to the remaining community pharmacies 
(n=1,247) from the start of June to the end of July 2018. An 
information sheet was included for community pharmacy 
staff which outlined the purpose of the study and asked 
staff to distribute to 10 consecutive patients accessing MAS 
who were willing to take part. This information was 
provided to encourage staff to distribute study packs 
consecutively to counter any distribution bias.  
Up to 10 patients from each community pharmacy who 
received an item on MAS throughout June and July 2018 
were eligible for recruitment. Each participant received the 
patient information sheet, initial questionnaire, and pre-
paid return envelope; consent forms were, as agreed by the 
Ethical Review Committee, not included as consent was 
implied by completion and return of the questionnaire. All 
patients accessing MAS were eligible to take part in the 
study providing the pharmacy staff deemed they had 
adequate English language literacy and comprehension to 
complete the questionnaires. Patients were not 
incentivised to take part in the study. Questionnaires were 
either completed online or posted by participants to the 
primary researcher who sent a follow up questionnaire one 
week after their MAS consultation as self-reported in their 
initial questionnaire, to those who provided contact details. 
A one-week follow up was used due to the relatively 
quicker recovery time of minor ailments and a 
consideration for the increased likelihood of recall bias 
should the follow-up occur at a later point. 
If participants wanted to be included in the follow-up 
study, they provided either a home postal address or e-mail 
address to receive the second questionnaire by post or 
electronically, respectively. The follow-up questionnaire 
was posted, or emailed, to reach the patients one week 
from the date of their reported pharmacy visit as 
documented in their initial questionnaire.  
Analysis  
Questionnaire responses were entered and analysed using 
IBM SPSS version 25. Frequency counts were performed for 
single and multi-response questions.  
Ethics approval  
Ethical approval was granted from NHS Scotland (South 
Central – Hampshire A Research Ethics Committee: 
18/SC/0229), each of the fourteen Scottish geographical 
health boards and University School Ethical Review panels 
at the Robert Gordon University and University of 
Strathclyde were obtained. 
RESULTS  
One thousand, one hundred and twenty-one 
questionnaires were returned (Table 1), with 
representation from all geographical health boards in 
Scotland (n=14; 100%). Of those who responded, most 
participants had accessed MAS before (n=1002; 89.4%), 
with 103 new users (9.2%) and 12 unsure (1.1%) if they had 
previously accessed the service. 
Symptoms of participants’ minor ailments that had led 
them to access MAS had lasted between 0 days and 60 
days with a mean of 4.6 (SD=6.6) days prior to accessing 
the service.  
Participants were asked to indicate why they had accessed 
care through MAS (Table 2). Several reasons informed the 
choice of using MAS with ‘Convenient location’ (n=748; 
67.1%), ‘No appointment needed’ (n=716; 64.3%), and 
‘Good relationship with the pharmacy already’ (n=700; 
62.8%) the most commonly reported.  
Participants were asked if MAS had not been available, 
which other services they would have used (Table 3). 
Table 1. Patient demographics (n=1,211) 
 n % 
Sex   
Female  861 76.8 
Male  251 22.4 
Undisclosed  9 0.08 
Occupational Status   
Employed full time  384 34.6 
Employed part time  349 31.5 
Unemployed  131 11.7 
Retired  349 31.1 
Full-time carer  32 2.9 
Full-time education  39 3.5 
Part-time education  2 0.2 
Rather not say  13 1.2 
MAS Eligibility   
<16 years  400 35.7 
Full time education and < 19 years  38 3.4 
Over 60 years  412 36.8 
Pregnant  41 3.7 
NHS Tax Credit  79 7 
Receiving income support  89 7.9 
Rather not Say  62 5.5 
Minor Ailment   
Allergy  328 29.3 
Skin  183 16.3 
Gastrointestinal  123 11 
Infection  113 10.1 
Respiratory  90 8 
Musculoskeletal pain  82 7.3 
Teething  59 5.3 
Head lice  28 2.5 
Headache  26 2.3 
Blocked ears  19 1.7 
Undisclosed  70 6.2 
Previous MAS Access   
Yes  1,002 89.4 
No  103 9.2 
Unsure  12 1.1 
Undisclosed 4 0.3 
Accessing MAS for    
Themselves  647 57.7 
A child  420 37.5 
Another adult  47 4.2 
Undisclosed   7 0.6 
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Participants were given the option to select more than one 
option to fully explore both services and self-care options. 
The two most frequent responses were ‘GP Practice’ 
(n=655; 59.0%) and ‘Bought Medicines Independently’ 
(n=629; 56.7%) with other responses reported as 10.6% 
(n=117) or less.  
All ten statements comprising the CARE measure scored a 
median response of ‘Excellent’, demonstrating a positive 
perception of the experience in the measured aspect of 
consultation and relational empathy (CARE): making you 
feel at ease, letting you tell your story, really listening, 
being interested in you as a whole person, fully 
understanding your concerns, showing care and 
compassion, being positive, explaining things clearly, 
helping you take control, and making a plan of action with 
you (Table 4).  
With regards to overall satisfaction, most participants 
scored MAS at 10 denoting full satisfaction (n=960; 87.2%), 
with the lowest scoring at 5 (n=4; 0.4%). Satisfaction 
responses were heavily skewed with both a median and 
interquartile range of 10.  
A one-week follow-up questionnaire was sent to those who 
opted in for this stage by means of contact details 
participants provided on the initial returned questionnaire 
(n=514; 45.9%) with an overall return of 327 questionnaires 
(29.2%). Follow-up at one week from the reported MAS 
pharmacy consultation was used to determine if 
participants had used any further services to treat their 
minor ailment (Table 5).  
Most MAS patients (n=279; 85.6%) reported that their 
minor ailment had been effectively treated, that they 
would use MAS again (n=326; 99.7%) and would 
recommend others to visit their community pharmacy for 
treatment of minor ailments (n=324; 99.4%). 
 
DISCUSSION 
This is the first study to demonstrate the national 
experiences and perceptions of patients accessing MAS via 
community pharmacy in Scotland. Overall satisfaction was 
very high and remained consistently so across the minor 
ailment groupings. This is in line with the satisfaction 
reported by the Scottish Health Council and wider in the 
UK.8,13 The reasons for selecting MAS for treatment 
demonstrated the perceived advantages of accessing and 
receiving treatment from a community pharmacy with 
‘Convenient location’, ‘No appointment needed’ and ‘Good 
relationship with the pharmacy already’ chosen most often.   
Participants reported a potentially high reliance on general 
practice with 59% of respondents reporting that they 
would have visited their GP if their pharmacy was not 
offering MAS. This study demonstrates the current 
potential impact of access to higher cost healthcare 
providers which already report high levels of workload and 
perceived staff burden.9,10 This is further enforced with the 
low percentage of respondents who required further 
Table 2. Reasons for accessing treatment via community 
pharmacy services (n=1,211) 
Reason for accessing MAS n % 
Convenient location  748 67.1 
No appointment needed  716 64.3 
Good relationship with the pharmacy  700 62.8 
Ailment not serious enough to see a GP  660 59.2 
Have used mas before  620 55.7 
Didn't have to travel far  468 42 
Seen/ heard to use 'Pharmacy First'  357 32 
Open when other services are not  172 15.4 
Table 4. CARE measure data (n=1,211) 




Making you feel at ease  (introducing him/herself, explaining his/her position, 
being friendly and warm towards you, treating you with respect; not cold or 
abrupt) 
0.4 1.4 5.9 20.4 69.8 2 
Letting you tell your ‘story’ (giving you time to fully describe your condition in 
your own words; not interrupting, rushing or diverting you  
0.3 0.7 5 22.7 70.1 1.3 
Really listening  (paying close attention to what you were saying; not looking at 
the notes or computer as you were talking) 
0.1 1.2 4.4 20.3 72.5 1.5 
Being interested in you as a whole person (asking/knowing relevant details 
about your life, your situation; not treating you as "just a number")  
0.4 1.8 6.1 19.4 68.3 4 
Fully understanding your concerns  (communicating that he/she had accurately 
understood your concerns and anxieties; not overlooking or dismissing anything) 
0.2 1 5.8 18.6 71.6 2.9 
Showing care and compassion  (seeming genuinely concerned, connecting with 
you on a human level; not being indifferent or "detached") 
0.5 1 5.2 18.6 72.8 1.9 
Being positive  (having a positive approach and a positive attitude; being honest 
but not negative about your problems) 
0.2 0.9 4.3 21.3 70.8 2.5 
Explaining things clearly  (fully answering your questions; explaining clearly, 
giving you adequate information; not being vague) 
0.4 0.4 5.1 19.2 71.9 3.1 
Helping you take control  (exploring with you what you can do to improve your 
health yourself; encouraging rather than "lecturing" you) 
0.7 1 4.6 20.1 59.7 13.8 
Making a plan of action with you  (discussing the options, involving you in 
decisions as much as you want to be involved; not ignoring your views) 
0.6 1.4 4.9 17.2 58.7 17.2 
N/A: does not apply. 
Table 3. Other services patients would have accessed (n=1,211) 
Other services that would have been used n % 
GP Practice  655 59.0 
Bought medicine independently   629 56.7 
NHS 24  117 10.6 
Online advice  114 10.3 
Advice from family/ friend  111 10.0 
No other service  37 3.3 
Accident & Emergency  23 2.1 
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access to care to treat their minor ailment. Most patients 
reported effective treatment through MAS which was 
confirmed at follow-up as was further access to healthcare 
services which demonstrated a minority of patients 
accessing further services to treat their minor ailments. 
This shows a constant standard with high levels of 
symptom resolution reported in 2013.14   
Perceptions of the consultation experience (using the CARE 
measure) were consistently reported as high. The positive 
perceptions and experiences of those who access the 
service demonstrate that the treatment of minor ailments 
at community pharmacies has the potential to fulfil the 
current national requirements for sustainable, high quality 
access to care and diversion from higher cost healthcare 
services.  
Strengths and limitations  
The study provides data not previously documented for the 
national perceptions and experiences of those using MAS 
with representation from all Scottish geographical health 
boards. With only two community pharmacies in Scotland 
not consenting to take part, this study showed high levels 
of buy-in from the pharmacy profession. This 
representational data enriches the knowledge and 
understanding of MAS. The use of a validated assessment 
tool21 and inclusion of follow-up responses recognise the 
recent recommendations on methodological considerations 
in the evaluation of minor ailment services.7  
Limitations of the study should be recognised as there may 
have been biases in self-report responses due to the nature 
of social desirability or the rating of a service that provides 
free care. The participants may have felt obliged to rate a 
service highly through receiving care at no personal cost.  
The percentage response rate of study packs distributed is 
unknown as this would require accurate recorded detail of 
which pharmacies received their packs and how many of 
these were distributed. It should be recognised that the 
scale of the project left control of distributing study packs 
with the community pharmacies, who may have selected 
patients of whom they would expect to give positive 
feedback of MAS.  
As recruitment occurred during June and July, those who 
participated in the study may have been more likely to 
present with seasonal conditions, such as hay fever, 
compared to other times of the year. Patients may also 
have been staying away from home on holiday when 
participating so may have been unfamiliar with the 
community pharmacy or community pharmacies may have 
been reluctant to give a study pack to unfamiliar patients. 
As different conditions present at different times of the 
year, it should be noted that this study captured data 
demonstrative of access to MAS in summer. 
As participants had to actively volunteer to participate in 
the follow-up of the study, this may have impacted on 
recruitment. Conversely, being presented with one 
questionnaire initially may also have impacted initial 
recruitment at baseline. 
Implications for research and practice  
A national evaluation of MAS had not previously been 
undertaken in Scotland but positive experiences of 
consultation and satisfaction have been reported in 
localised studies.9,12 Shifting the onus of minor ailment 
treatment towards community pharmacy can alleviate 
pressure on appointments in general practice and this has 
been demonstrated in the Inverclyde region of Scotland 
where additional prescribing resources at community 
pharmacies an average of 5 hours’ direct GP time per 
practice per week.9 This study reports, on a national scale, 
that 59% of those accessing MAS would have accessed 
general practice had the community pharmacy service not 
been available. Given recent economic estimates, the 
overall cost of treatment for each minor ailment from 
community pharmacy is GBP 53.04 less than that of general 
practice.25 With each visit to a community pharmacy for 
treatment of minor illness in place of general practice 
reducing the cost of care by over GBP 50, MAS provides a 
potentially significant saving for NHS Scotland. However, 
the funding model for community pharmacy may need to 
be revised considering these findings. 
This study has captured the national experiences of those 
accessing treatment on MAS and demonstrates high levels 
of satisfaction and perceived quality of consultation, 
regardless of the presenting minor ailment across all 
geographical health boards in Scotland. Such satisfaction of 
the service coupled with the reduction in accessing higher 
cost services exemplifies the contribution of MAS towards 
minimising health inequalities and improving access to 
care, encouraging the improved utilisation of pharmacy 
services. The reported reasons for accessing community 
pharmacy for treatment should also be considered for 
future refinement of signposting those with minor ailment 
conditions away from settings such as general practice to 
promote equal access for healthcare.  
These findings should be considered in future assessment 
of the capacities of community pharmacy practice and used 
as a baseline to monitor changes in patient experience and 
satisfaction following future refinement of the service. The 
proposed Pharmacy First Scotland initiative will widen 
eligibility for free treatment for minor ailments and 
potentially shift public perception of the treatment, 




Community pharmacy continues to evolve to meet the 
healthcare needs of the population in Scotland and 
elsewhere with services like MAS are making an ever 
growing contribution. The evaluation of these services is 
critical for the informed development and refinement of 
Table 5. Other services patients had accessed at follow up 
(n=327) 
Follow Up Use of Services n % 
No other service  281 85.9 
GP Practice  21 6.4 
Advice from family/ friend  10 3.1 
Bought medicine independently   9 2.8 
Online advice  5 1.5 
NHS 24  (NHS Telephone Healthline) 1 0.3 
Accident & Emergency  0 0 
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healthcare services. MAS in Scotland is well received with 
high overall satisfaction and positive experiences. The 
lower overall cost of access for MAS shows the economic 
viability of the service. As these types of service emerge, it 
is important to continue evaluation to demonstrate 
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